$IART
Integra Lifesciences Holdings Corp

2013 Q1 Form 10-Q Financial Statement

#000091752013000041 Filed on May 02, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $196.7M $196.2M
YoY Change 0.24% 8.36%
Cost Of Revenue $79.61M $74.68M
YoY Change 6.61% 17.41%
Gross Profit $117.0M $121.5M
YoY Change -3.68% 4.64%
Gross Profit Margin 59.52% 61.94%
Selling, General & Admin $103.0M $87.41M
YoY Change 17.79% 15.17%
% of Gross Profit 87.97% 71.94%
Research & Development $12.72M $11.91M
YoY Change 6.75% -2.36%
% of Gross Profit 10.86% 9.8%
Depreciation & Amortization $11.39M $12.58M
YoY Change -9.44% 25.76%
% of Gross Profit 9.73% 10.35%
Operating Expenses $115.7M $99.32M
YoY Change 16.47% 9.03%
Operating Profit -$2.190M $17.47M
YoY Change -112.54% -16.31%
Interest Expense $4.800M $7.929M
YoY Change -39.46% -246.83%
% of Operating Profit 45.39%
Other Income/Expense, Net -$974.0K -$323.0K
YoY Change 201.55% -46.17%
Pretax Income -$7.901M $9.593M
YoY Change -182.36% -35.18%
Income Tax -$1.873M $2.900M
% Of Pretax Income 30.23%
Net Earnings -$6.028M $6.693M
YoY Change -190.06% -41.73%
Net Earnings / Revenue -3.07% 3.41%
Basic Earnings Per Share -$0.22 $0.24
Diluted Earnings Per Share -$0.22 $0.23
COMMON SHARES
Basic Shares Outstanding 27.80M shares 28.35M shares
Diluted Shares Outstanding 27.80M shares 28.49M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.70M $112.4M
YoY Change -20.2% 7.66%
Cash & Equivalents $89.69M $58.64M
Short-Term Investments $53.80M
Other Short-Term Assets $65.90M $60.90M
YoY Change 8.21% 1.33%
Inventory $179.6M $172.5M
Prepaid Expenses
Receivables $111.9M $114.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $447.1M $459.7M
YoY Change -2.75% 8.11%
LONG-TERM ASSETS
Property, Plant & Equipment $179.4M $136.8M
YoY Change 31.11% 33.46%
Goodwill $292.3M
YoY Change
Intangibles $212.3M
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.785M $35.70M
YoY Change -72.59% 72.46%
Total Long-Term Assets $709.4M $698.7M
YoY Change 1.54% 20.09%
TOTAL ASSETS
Total Short-Term Assets $447.1M $459.7M
Total Long-Term Assets $709.4M $698.7M
Total Assets $1.156B $1.158B
YoY Change -0.16% 15.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.90M $35.60M
YoY Change 23.31% 0.85%
Accrued Expenses $34.55M $65.00M
YoY Change -46.84% 18.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $105.8M $104.6M
YoY Change 1.13% -35.95%
LONG-TERM LIABILITIES
Long-Term Debt $521.4M $523.0M
YoY Change -0.31% 78.07%
Other Long-Term Liabilities $14.04M $16.90M
YoY Change -16.93% 45.69%
Total Long-Term Liabilities $14.04M $539.9M
YoY Change -97.4% 76.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $105.8M $104.6M
Total Long-Term Liabilities $14.04M $539.9M
Total Liabilities $646.6M $649.9M
YoY Change -0.51% 35.57%
SHAREHOLDERS EQUITY
Retained Earnings $298.0M
YoY Change
Common Stock $590.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $367.1M
YoY Change
Treasury Stock Shares 8.903M shares
Shareholders Equity $509.9M $508.5M
YoY Change
Total Liabilities & Shareholders Equity $1.156B $1.158B
YoY Change -0.16% 15.03%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$6.028M $6.693M
YoY Change -190.06% -41.73%
Depreciation, Depletion And Amortization $11.39M $12.58M
YoY Change -9.44% 25.76%
Cash From Operating Activities $7.846M $32.32M
YoY Change -75.72% 51.73%
INVESTING ACTIVITIES
Capital Expenditures $10.85M $10.41M
YoY Change 4.24% -276.47%
Acquisitions $2.766M $175.0K
YoY Change 1480.57%
Other Investing Activities -$2.200M -$53.40M
YoY Change -95.88%
Cash From Investing Activities -$13.09M -$63.84M
YoY Change -79.5% 981.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $257.0K -$12.56M
YoY Change -102.05% -71.78%
NET CHANGE
Cash From Operating Activities $7.846M $32.32M
Cash From Investing Activities -$13.09M -$63.84M
Cash From Financing Activities $257.0K -$12.56M
Net Change In Cash -$4.984M -$44.08M
YoY Change -88.69% 51.47%
FREE CASH FLOW
Cash From Operating Activities $7.846M $32.32M
Capital Expenditures $10.85M $10.41M
Free Cash Flow -$3.007M $21.91M
YoY Change -113.73% -19.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
43875000 USD
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
36742000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111944000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
114916000 USD
CY2012Q1 us-gaap Accretion Expense
AccretionExpense
3528000 USD
CY2013Q1 us-gaap Accretion Expense
AccretionExpense
1610000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34553000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31768000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4797000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11281000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
587301000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
589948000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10528000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7221000 USD
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
760000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
545000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3551000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4720000 USD
CY2013Q1 us-gaap Assets
Assets
1156491000 USD
CY2012Q4 us-gaap Assets
Assets
1163599000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
453051000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
447059000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89691000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96938000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58642000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100808000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-42166000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7247000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36852000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36959000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
369000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
370000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13639000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10534000 USD
CY2013Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
199511000 USD
CY2012Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
197672000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
74675000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
80268000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
196696000 USD
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
178718000 USD
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
400000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1055000 USD
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-983000 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3868000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3505000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
39100000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
38470000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15743000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15957000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5397000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5393000 USD
CY2013Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2012Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2011Q1 us-gaap Defined Benefit Plan Curtailments
DefinedBenefitPlanCurtailments
300000 USD
CY2012Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
144000 USD
CY2013Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
100000 USD
CY2013Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
137000 USD
CY2012Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
160000 USD
CY2013Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
37000 USD
CY2012Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
22000 USD
CY2012Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
6000 USD
CY2013Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11389000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12576000 USD
CY2013Q1 us-gaap Derivative Description Of Terms
DerivativeDescriptionOfTerms
August 10, 2015
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4126000 USD
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3644000 USD
CY2012Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-449000 USD
CY2013Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-524000 USD
CY2012Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-285000 USD
CY2013Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-9000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
19400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12500000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
23000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
137117000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
132646000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2263000 USD
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1911000 USD
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.296
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.302
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23484000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34914000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
23000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16600000 USD
CY2012Q1 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
0 USD
CY2013Q1 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
-1865000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
292278000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-534000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
853000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8885000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
294067000 USD
CY2012Q4 us-gaap Goodwill Gross
GoodwillGross
294067000 USD
CY2012Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
USD
CY2013Q1 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-1905000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5755000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9593000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1705000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2900000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
900000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-515000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2121000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4800000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2109000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
391000 USD
CY2013Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-364000 USD
CY2012Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
399000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
115000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
152000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2872000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1619000 USD
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
143000 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
212267000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
212274000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
7929000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
4800000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102401000 USD
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
107354000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
179558000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
171806000 USD
CY2012Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
29461000 USD
CY2013Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
29700000 USD
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42504000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39944000 USD
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
63000 USD
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
378000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
646602000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
645824000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1156491000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1163599000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
105780000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
106929000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
257000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12560000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13087000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63835000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32318000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7846000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4050000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
6693000 USD
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
3800000 USD
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 Segment
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17467000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-44000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10359000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9785000 USD
CY2013Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
0 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-4000 USD
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6845000 USD
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6780000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6484000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
105000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
296000 USD
CY2012Q1 us-gaap Other General Expense
OtherGeneralExpense
49217000 USD
CY2013Q1 us-gaap Other General Expense
OtherGeneralExpense
61227000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13955000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14039000 USD
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-277000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-974000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-323000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
175000 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2766000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10412000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10853000 USD
CY2013Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2012Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
53248000 USD
CY2012Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2013Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27396000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30291000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
532000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
250000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
234000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179352000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
177898000 USD
CY2013Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2012Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
12813000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12716000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11912000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
302023000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
297973000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
196652000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
196185000 USD
CY2012Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
321875000 USD
CY2013Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
321875000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87411000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100161000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2072000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2070000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1700000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1700000 shares
CY2013Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
75000000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
517775000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
509889000 USD
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
8903000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
8903000 shares
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2013Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
400000 USD
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27796000 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28488000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28345000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27796000 shares
CY2011Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-4307000 USD
CY2012Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-4159000 USD
CY2013Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-3644000 USD
CY2012Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-4143000 USD
CY2012Q4 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
344913000 USD
CY2013Q1 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
349391000 USD
CY2013Q1 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
212274000 USD
CY2012Q4 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
212267000 USD
CY2013Q1 iart Effective Tax Rate Estimate
EffectiveTaxRateEstimate
0.010
CY2013Q1 iart Inventory Medical Device Tax
InventoryMedicalDeviceTax
2200000 USD
CY2013Q1 iart Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-6789000 USD
CY2013Q1 iart Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-305000 USD
CY2013Q1 iart Segment Profit Loss
SegmentProfitLoss
64734000 USD
CY2012Q1 iart Segment Profit Loss
SegmentProfitLoss
71404000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000917520
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28064689 shares
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
INTEGRA LIFESCIENCES HOLDINGS CORP
CY2013Q1 dei Trading Symbol
TradingSymbol
iart

Files In Submission

Name View Source Status
0000917520-13-000041-index-headers.html Edgar Link pending
0000917520-13-000041-index.html Edgar Link pending
0000917520-13-000041.txt Edgar Link pending
0000917520-13-000041-xbrl.zip Edgar Link pending
exhibit1010-gorelicksevera.htm Edgar Link pending
exhibit103-performanceince.htm Edgar Link pending
exhibit104amendmenttosecon.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
iart-20130331.xml Edgar Link completed
iart-20130331.xsd Edgar Link pending
iart-20130331x10q.htm Edgar Link pending
iart-20130331xexx311.htm Edgar Link pending
iart-20130331xexx312.htm Edgar Link pending
iart-20130331xexx321.htm Edgar Link pending
iart-20130331xexx322.htm Edgar Link pending
iart-20130331_cal.xml Edgar Link unprocessable
iart-20130331_def.xml Edgar Link unprocessable
iart-20130331_lab.xml Edgar Link unprocessable
iart-20130331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending